Detection of Subclinical Atherosclerosis in Asymptomatic Individuals (Decide CTA)
Prospective Detection of Subclinical Atherosclerosis in Asymptomatic Individuals With High Likelihood of Coronary Artery Disease With a Novel, Low-Radiation Volumetric Computed Tomography Approach
Sponsor: Piedmont Healthcare
This observational or N/A phase trial investigates Coronary Artery Disease and is currently completed. Piedmont Healthcare leads this study, which shows 12 recorded versions since 2009 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Completed NA
Status: Unknown Status → Completed · Phase: EARLY_PHASE1 → NA
-
Aug 2017 — Dec 2017 [monthly]
Unknown Status EARLY_PHASE1
-
Feb 2017 — Aug 2017 [monthly]
Unknown Status EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status Phase 0
First recorded
Jan 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Piedmont Healthcare
For direct contact, visit the study record on ClinicalTrials.gov .